Gastrointestinal

Uses pili-mediated gut adhesion and soluble immune factors to shorten infectious diarrhea in children and reduce antibiotic-associated diarrhea, with RCT and meta-analysis support.

Uses lactase production and bile salt hydrolase activity to improve lactose digestion and lipid profiles, with RCT evidence.

Uses mannose-specific gut adhesion to reduce IBS symptoms and improve iron status in deficient athletes, with RCT support.

Uses adhesion and bacteriocin production to reduce H. pylori colonization and support gut barrier function, with RCT evidence.

Uses antimicrobial compounds and gut motility modulation to reduce infant colic crying time, with RCT and meta-analysis support.

Uses fatty acid metabolism modulation to reduce abdominal adiposity and improve H. pylori-associated dyspepsia, with human RCT support.

Uses gut barrier modulation and neuroactive metabolites to reduce antibiotic-associated diarrhea and anxiety symptoms, with RCT evidence.

Uses gut colonization and immune signaling to reduce infectious diarrhea in children and support gut barrier development, with RCT evidence.

Produces bacteriocin ABP-118 to inhibit pathogens and modulate mucosal immunity, with IBD model evidence.

Uses cell wall polysaccharides to modulate immunity and reduce IBS symptoms, with RCT evidence.

Produces lactase to improve lactose digestion and supports gut barrier function as a yogurt starter.

Consumes human milk oligosaccharides to produce anti-inflammatory metabolites, reducing IBS symptoms with RCT support.

Uses gut adhesion and bifidogenic metabolites to reduce antibiotic-associated diarrhea and support infant gut development, with RCT evidence.

Modulates gut transit time and immune cell activity to improve constipation and reduce infections, with RCT support.

Uses competitive pathogen exclusion and immune modulation to reduce infections and allergy symptoms, with RCT support.

Uses spore-based survival and protease production to improve protein absorption and reduce exercise-induced muscle damage, with RCT evidence.

Uses spore germination in the small intestine and bile salt hydrolase activity to improve blood lipids and gut barrier function, with RCT evidence.

Uses protease-mediated toxin degradation and pathogen inhibition to reduce antibiotic-associated diarrhea and support H. pylori eradication, with meta-analysis support.